$1.61 billion dedicated to building businesses that will operate at the forefront of medicine. 

Areas of Expertise

  • Therapeutics

    Our mission is to create new drugs that solve meaningful clinical problems. Our resources and long term perspective allow us to build companies around important innovations and to support them through commercialization and beyond.

    Portfolio Team
  • Medical Devices

    We seek to fund important therapeutic device innovation that fills unmet medical needs. Our team's experience and operational expertise, coupled with our long term funding perspective, lets us support development from ideation to commercialization.

    Portfolio Team

Portfolio Highlights

Recent News

Nov 01, 2017

Syntimmune Announces Clinical Data from First-in-Human Trial of Lead Candidate

Read more

Nov 01, 2017

Braeburn Announces FDA Advisory Committee Recommends Approval of CAM2038

Read more